The management outcome of heart failure reduced ejection fraction with or without angiotensin receptor neprilysin inhibitor in Kelantan

被引：0
|
作者：
Wu, J. T. [1 ]
Othman, M. K. [1 ]
Isa, W. Y. H. W. [1 ]
机构：
[1] Hosp Univ Sains Malaysia, Cardiol Unit, Kota Baharu, Kelantan, Malaysia
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2022年 / 369卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
10
引用
收藏
页码：5 / 6
页数：2
相关论文
共 50 条
  • [31] Soluble neprilysin predicts outcome in patients with heart failure with reduced ejection fraction
    Pavo, N.
    Wurm, R.
    Korn, S.
    Osorio, E.
    Huelsmann, M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 : S325 - S325
  • [32] Effects of the angiotensin receptor-neprilysin inhibitor/sacubitril-valsartan administration on quality of life and outcome in heart failure with reduced ejection fraction: a meta analysis
    Dewi, Kadek Intan Murti
    Pintaningrum, Yusra
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0F)
  • [33] Angiotensin Receptor-neprilysin Inhibitor Therapy is Associated With Improved Echocardiographic Parameters in Chronic Heart Failure Patients With Reduced Ejection Fraction
    Poglajen, Gregor
    Drofenik, Ajda Anzic
    Jurca, Dominika
    Zemljic, Gregor
    Cerar, Andraz
    Okrajsek, Renata
    Sebestjen, Miran
    Frljak, Sabina
    Vrtovec, Bojan
    CIRCULATION, 2019, 140
  • [34] Clinical and Socioeconomic Determinants of Angiotensin Receptor-Neprilysin Inhibitor Prescription at Hospital Discharge in Patients With Heart Failure With Reduced Ejection Fraction
    Tran, Jeffrey S.
    Loveland, Macklin G.
    Alamer, Ahmad
    Pina, Ileana L.
    Sweitzer, Nancy K.
    CIRCULATION-HEART FAILURE, 2022, 15 (11) : E009395
  • [35] Outcomes of Angiotensin Receptor-Neprilysin Inhibitor Prescriptions for Patients with Heart Failure and Reduced Ejection Fraction in Real World Clinical Practice
    Malloy, Rhynn J.
    Smith, Katelyn V.
    Stern, Gretchen M.
    Desai, Akshay S.
    JOURNAL OF CARDIAC FAILURE, 2018, 24 (08) : S28 - S28
  • [36] Status and timing of angiotensin receptor-neprilysin inhibitor implementation in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure Registry
    Stolfo, Davide
    Benson, Lina
    Lindberg, Felix
    Dahlstrom, Ulf
    Kack, Oskar
    Sinagra, Gianfranco
    Lund, Lars H.
    Savarese, Gianluigi
    EUROPEAN JOURNAL OF HEART FAILURE, 2024,
  • [37] Angiotensin Receptor-Neprilysin Inhibition (ARNI) Therapy and Reverse Remodeling in Heart Failure With Reduced Ejection Fraction
    Drazner, Mark H.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (11): : 1051 - 1053
  • [38] Angiotensin Receptor Neprilysin Inhibition Improves Arterial Stiffness And Endothelial Function In Heart Failure With Reduced Ejection Fraction
    Nathaniel, Sangeetha D.
    McGinty, Shane
    Edwards, David G.
    Farquhar, William B.
    Melissa, A.
    Hosmane, Vinay
    Wenner, Megan M.
    HYPERTENSION, 2020, 76
  • [39] Effects of angiotensin receptor neprilysin inhibition on P-wave dispersion in heart failure with reduced ejection fraction
    Okutucu, Sercan
    Fatihoglu, Sefik Gorkem
    Sabanoglu, Cengiz
    Bursa, Nurbanu
    Sayin, Begum Yetis
    Aksoy, Hakan
    Oto, Ali
    HERZ, 2021, 46 (SUPPL 1) : 69 - 74
  • [40] Early initiation of angiotensin receptor-neprilysin inhibitor improves heart failure outcome, natriuretic peptides and ejection fraction in patients with a recent hospitalisation with heart failure
    James, A. B.
    Williams, R. A.
    Vaughan, S.
    Ashton, M.
    Wong, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 380 - 380
12345